ARCHIVES

PhRMA’s New Ethics Code Prohibits Trinkets, Dinners; Speaking Fees Still OK.

This article is from The Cancer Letter archive.

Vol. 34 No. 27 | July 11, 2008

Download PDF Visit The Full Archive

Related Articles

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

NCAB Seeks Greater flexibility In Grants Target To Aid P01s

May 31, 1991

Decision To Screen For Prostate Cancer Should Include Patients, ACS Panel Says

March 21, 1997

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002

NCI Plans a Catalog Of Research Tools

April 30, 1999